CD40 is a member of the nerve growth factor receptor family, showing a significant homology to the Hodgkin's disease (HDI-associated antigen CD30 and is capable of transduce growth signals in a number of cell types. A series of 312 lymphoma samples, including 139 cases of HD, 32 cases of CD30' anaplastic large cell (ALC) lymphomas, 141 cases of other non-Hodgkin's lymphomas (NHLs), and a panel of HDor NHL-derived cell lines, were evaluated for CD40 expression by immunostaining of paraffin embedded sections, cell smears and flow cytometry. CD40 was strongly expressed with a highly distinct pattern of staining on Reed-Sternberg Although CD40 has been extensively studied on B-cell populations, certain carcinomas, and more recently on myeloma plasma cells,I7 little is known about its functional significance in other tumor cell types. We were particularly interested in investigating the expression and functional role of CD40 on Reed-Stemberg (RS) cells, the putative neoplastic cells of HD, owing to its significant homology with the HD-associated antigen CD30.7.8 This latter antigen is expressed on the surface of RS cells, usually in association with CD15, in up to 80% of HD case^.'^.'^ For this reason, CD30 is commonly regarded as a valuable diagnostic and clinical marker characteristic for HD and related malignancies, including CD30-positive anaplastic large cell (ALC) lymphomas. ''~20-z2
D40 IS A 50-kD glycoprotein expressed on the surface of peripheral blood and tonsillar B cells, most B-cell leukemias and lymphomas, a number of carcinomas, and relatively few normal epithelial cells."6 In tissue sections of lymphoid organs, anti-CD40 monoclonal antibodies (MoAbs) show a pan-B reactivity and typically stain interdigitating reticulum cells and follicular dendritic c e l l~.~.~ Sequence analysis has shown that CD40 is a member of the tumor necrosis factor (TNF)/nerve growth factor (NGF) receptor ~uperfamily,'.~ which also includes the Hodgkin's disease (HD)-associated molecule CD30.' CD40 is a surface receptor capable of transducing regulatory signals for a number of important cellular functions including proliferat i~n ,~"~ differentiation," and intercellular communication.I3 CD40 acts as a receptor for a specific ligand (CD40L) ' Although CD40 has been extensively studied on B-cell populations, certain carcinomas, and more recently on myeloma plasma cells,I7 little is known about its functional significance in other tumor cell types. We were particularly interested in investigating the expression and functional role of CD40 on Reed-Stemberg (RS) cells, the putative neoplastic cells of HD, owing to its significant homology with the HD-associated antigen CD30.7.8 This latter antigen is expressed on the surface of RS cells, usually in association with CD15, in up to 80% of HD case^.'^.'^ For this reason, CD30 is commonly regarded as a valuable diagnostic and clinical marker characteristic for HD and related malignancies, including CD30-positive anaplastic large cell (ALC) lymphomas. ''~20- z2 In this study, we wished to define the pattern of expression of CD40 on RS cells and to assess its potential utility for the immunodetection of tumor cells in HD. Furthermore, the differential expression of CD40 and CD40L in HD-and nonHodgkin's lymphomas (NHL)-derived human cell lines, and the effects of CD40L on the clonogenic growth of cultured RS cells were evaluated. The role of the CD40/CD40L pathway in mediating T-cell adhesion to RS cell lines was also investigated.
MATERIALS AND METHODS
Tissue samples. The study included tissue samples of 139 cases of HD covering all histologic subtypes, and 173 cases of NHL including 32 cases of CD30-positive ALC lymphoma (Table 1) . Nonspecific reactive lymphadenopathies and lymph node samples with reactive conditions, such as sarcoidosis (3 cases), and toxoplasmosis (2 cases) were also examined. Tissues were fixed in Bouin solution or formalin. When feasible (38 HD cases, 76 NHL cases, and 17 ALC lymphoma cases), a portion of unfixed tissue was snap frozen in liquid nitrogen and stored at -80°C. Pathologic specimens were classified according to the Working Formulation and to the updated Kiel classification for NHL. The morphologic criteria used to identify ALC lymphoma were described by Agnarsson * The expression of B-cell associated markers on RS cells was found in 28 HD cases (11 lymphocyte predominance, 12 nodular sclerosis, 4 mixed cellularity, 1 lymphocyte depletion), whereas the expression of T-cell-associated markers was found in 6 cases, all of the NS subtype. The RS cells in the remaining 105 HD cases were classified as of undetermined (non-B-non-T, 102 cases; T and B, 3 cases) phenotype.
t The lymphocyte predominance subset included 10 cases of the nodular variant and 4 cases of the diffuse variant.
*Small lymphocytic and immunoblastic lymphoma (Richter's syn- 5 One case with lymph node involvement by mycosis fungoides. drome).
France) was applied to paraffin-embedded tissues from all lymphoma cases included in the study. Deparaffinized and cryostat sections were used for further immunopbenotyping and lineage assignment of lymphoma cases. Source and specificities of antibodies used in this study have been reported in detail previously. For personal use only. on August 16, 2017 . by guest www.bloodjournal.org From CD40 MoAb 89, anti-CD30 MoAbs K-l and HRS-4, and anti-CD32 MoAb 2E1 (Immunotech, Marseille, France) and then assayed for clonogenic growth as described above. As a further control, three different irrelevant purified MoAbs of the same isotype were used. The effects of the simultaneous stimulation with soluble CD4OL (1:25 voYvol) and recombinant human interleukin-9 (IL-9; R&D Systems, MN) (5.0 U/mL) on the clonogenic growth of the IL-9-sensitive HD cell line K"H2,36 were also analyzed.
Adhesion of CD4OL expressing T cells to HD cell lines. Peripheral CD4+ T cells from normal donors were purified by FicollHypaque centrifugation followed by negative selection with anti-CD19 plus anti-CD8 immunomagnetic beads (Dynabeads, Dynal, Norway) as described:' and activated to express CMOL by exposure to TPA (10 ng/mL) and of ionomycin (1 pg/mL) for 8 hours. Srarisrics. Results of fluorescence and clonogenic assays represent the mean 2 SEM derived from at least three different experiments. Statistical significance of differences was evaluated by Student's t-test.
RESULTS
Expression of CD40 in nonneoplastic lymph nodes. In tissue sections of reactive lymph nodes, anti-CD40 MoAbs showed a pan-B reactivity, staining follicular-mantle and germinal-center B-cells, in addition to interdigitating cells. Anti-CD40 MoAbs were not reactive with a population of larger lymphoid cells, with a characteristic perifollicular distribution pattern, which conversely expressed the CD30 antigen. In both toxoplasmosis and sarcoidosis lymphadenitis, "epithelioid" histiocytes were strongly stained.
Expression of CD40 in HD. Expression of CD40 on RS cells from 139 cases of HD, grouped according to the histologic subtypes is shown in Table 1 . RS cells were strongly stained by anti-CD40 MoAb 89 in all cases of HD examined, irrespective of the histologic subtype (Fig 1, A through C) and of their antigenic phenotype (T, B, non T-non B) ( Table  1) . In all cases, 90% to 100% of RS cells and variants were labeled. The staining was usually very intense on the cell membranes ( Fig 1B) ; it was associated with a diffuse cytoplasmic staining of variable intensity and with a strong dotlike pattern in the paranuclear area (Fig 1, B and C) . With the exception of the lymphocyte predominance (LP) subtype, almost all cases were found to express the CD15 (93%) and the BerH2 (CD30) (99%) antigens. MoAb anti-BLA.36 reacted with RS cells and variants from all HD subtypes in only a fraction (19/25) of the cases studied.
In most cases, where residual normal lymphoid tissue was present, interdigitating reticulum cells as well as B lymphocytes along with macrophages, epithelioid histiocytes, and endothelial cells were stained by the anti-CD40 MoAb 89.
Expression of CD40 in NHLs. NHL cases were classified histopathologically as shown in Table 1 . The expression of B-cell-associated markers was found in 137 of 173 evaluated cases, whereas 23 cases were classified as T-cell lymphomas according to their immunophenotypes, and 13 cases were classified as of undetermined (non T-non B) phenotype (Table 1) .
Immunoreactivity of anti-CD40 MoAb 89 in the total series of NHL other than ALC lymphoma is listed in Table 1 . As expected, anti-CD40 MoAb reacted with 105 of 127 Bcell lymphomas studied. However, the staining pattern was of moderate intensity, with a homogeneous diffuse staining both on the cell membranes and cytoplasms. Dot-like or punctate paranuclear staining was never observed in B-cell NHL. The CD40 antigen was not detected in all the 14 Tcell lymphomas other than ALC lymphoma.
The results of anti-CD40 reactivity with tumor cells in 32 cases of Ki-l/CD30-positive ALC lymphoma are shown in Table 1 . In all cases, 100% of neoplastic cells were stained by BerH2/CD30 antibody, whereas anaplastic large tumor cells reacted with anti-CD40 MoAbs in only about one third (12/32, 37%) of the cases. Interestingly, CD40-expressing ALC lymphoma cells were of either B-cell (5 cases), T-cell (2 cases), or undetermined phenotype (5 cases) ( Table 1) . In CD40-positive cases, 50% to 100% of tumor cells were labeled, displaying a moderate to strong staining on the cell membranes. However, staining was less intense than that usually observed in the RS cells of HD, and cytoplasmic staining or dot-like paranuclear positivity was not appreciable (Fig ID) .
Expression of CD40 and CD4OL in HD-and ALC lymphoma-derived cell lines. On cytospin preparations, HD cell lines were consistently stained by anti-CD40 MoAbs irrespective of their antigenic profiles, which encompassed B (K"H2), T (HDLM-2), and non T-non B (L-428) phenot y p e~.~~ Cultured RS cells were characterized by a strong granular cytoplasmic staining with anti-CD40 MoAbs ( Fig   2) ; on a number of cells, this staining was associated with labeling on the cell membranes, leading to an overall picture closely resembling that observed by us on RS cells in HD tissues. CD40 was not detected on ALC lymphoma cells Karpas-299, whereas all cell lines were stained by anti-CD30 MoAbs.
Flow cytometry profiles of HD-, ALC lymphoma-derived, and B-cell leukemiallymphoma cell lines after staining with anti-CD40 MoAb 89 are shown in Fig 3. Specific fluorescence intensity of CD40 staining in HD-derived cell lines (L-428, K"H2, HDLM-2) was strikingly higher than in all other cell lines tested, which encompassed different stages of B-cell differentiation, from pre-B-cells to plasma cells, and included the ALC lymphoma cell line Karpas-299 ( Figs  3 and 4) . CD40 staining intensity on HD cell lines ranged from 328,911 to 480,706 MESF, whereas in all other cell types, it ranged from 5,280 to 178,586 (Fig 4) Fig 5B. CD40L (1:25 vol/vol) was able to produce a 2.2-fold increase in colony formation with respect to cells exposed to control COS-7 supernatants. Such effect was enhanced by recombinant IL-9 (5 U/mL) yielding to 3.9-and 2.3-fold increases in the total number of colonies over cells exposed to control COS-7 supernatants and COS-7 supernatants plus IL-9, respectively ( P < .OOl). The exposure of L-428 (Fig 6, A and B) and KM-H2 (Fig 6, C and For personal use only. on August 16, 2017 . by guest www.bloodjournal.org From CD40 IN HODGKIN' S DISEASE E) cells to soluble CD40L also resulted in a striking increase in colony size that appeared twofold to threefold larger than in control cultures added with equal concentrations of COS-7 supernatants. The simultaneous exposure of KM-H2 cells to soluble CD40L and recombinant L -9 (Fig 6F) , resulted in the generation of colonies larger than those developed in the cultures added with either IL-9 (Fig 6D) or CD4OL (Fig  6E) alone. Finally, colony cells exposed to soluble CD4OL displayed an increased in vitro survival (up to 20 days) as compared with control colonies that underwent degeneration starting from the 16th day of culture (data not shown).
B-NHL
Inhibition of T-cell adhesion to HD cells by anti-CD40 MoAbs. To evaluate the involvement of CD40-CD40L pathway in T-cell adhesion to RS cells, rosette formation experiments with the L-428 HD cell line were performed. For such a purpose, purified peripheral CD4+ T cells activated in vitro to express CD4OL after an 8-hour incubation with TPA and i~nomycin,'~ and a Jurkat T-cell clone expressing CD40L, were used. In both cases, expression of CD40L was monitored by fluorescence staining with the anti-CD40L MoAb M90 (not shown). Up to 35% of L-428 cells were able to bind activated CD4+ T cells (Fig 7) . Antibodies to CD40 were able to inhibit rosette formation by more than 60%. Blocking of CD58/CD2 and CD1 ldCD54 adhesion pathways by MoAbs resulted in 46% and 89% inhibition of CD4+ T-cell rosetting to L-428, respectively. Simultaneous blocking of all three adhesion pathways (CD4O/CD4OL, CD1 ldCD54, CD58/CD2) by MoAbs, resulted in the complete inhibition of rosette formation (Fig  7) . Similarly, anti-CD40 MoAbs were able to produce a 68% inhibition of Jurkat T-cell rosetting to L-428 cells (Fig 7,  lower panel) . However, simultaneous blocking of CD40/ CD40L, CD1 ldCD54, and CD58/CD2 adhesion pathways did not result in the complete inhibition of rosette formation of Jurkat T cells with L-428. In all experiments, negative control MoAbs to HLA class I only marginally inhibited rosette formation (Fig 7) . Similarly, anti-CD40 MoAbs were able to induce a 55% inhibition of activated CD4+ T-cell rosetting to KM-H2 cells (not shown).
DISCUSSION
Extensive immunophenotypic analysis has shown heterogeneous antigenic profiles on RS cells39 and there have been no convincing indications of RS cell-specific antigens. Based on these evidences, a combination of several markers, including activation antigens (CD30, CD15, CD25, CD71), HLA-related molecules (CD74, HLA-DR), T-and B-cell- cytoplasmic or dot-like paranuclear reactivity. However, the absence of CD40 could represent a further tool to rule out HD if the differential diagnosis was HD versus ALC lymph~ma.~' By analyzing a limited number of human lymphomas with the MoAb BB-20, O'Grady et also have detected CD40 on RS cells in only 26 of 37 HD and in 2 of 12 B-cell NHL cases. These findings are in apparent contrast with our data on HD, and with the present and previous studies indicating that more than 80% of B-cell NHL express CD40.',6,45448 Such discrepancies, which appear not to be limited to HD, may be explained in part by an exquisite sensitivity to fixation procedures of the CD40 epitope recognized by the MoAb BB-20, and/or to a low affinity for CD40 of this MoAb. The use of different immunodection procedures (ie, flow cytometry v immunohistochemistry and APAAP staining v ABC) should be also taken into account.
The surface density of CD40 on RS cell lines was significantly higher than on all other cell types analyzed in our study. This finding may turn of functional relevance because CD40 engagement may result in active signal transduction?." in the absence of costimulation, provided that the molecule is expressed at a critical threshold level of cell surface d e n~i t y ,~~'~~'~~" and the lack of growth stimulation by anti-CD40 MoAbs in some B-cell leukemias has been related to a low membrane level of CD40 on tumor c e k 6 We have shown here that CD40 engagement by soluble CD40L promotes the clonogenic growth of HD cell lines and enhances their survival in vitro, as indicated by a striking in- Our results indicating that CD40 expressed on HD cells is functionally active both as an adhesion molecule and a growth signal transducer suggest that it may play a role in the regulation of RS cells expansion and in the contactdependent interactions of these cells with cytokine-producing T lymphocytes within the HD microenvironment,
